首页 » 细胞株Cell Lines 32-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心

细胞株Cell Lines 32-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心

  • 价  格:¥19200
  • 货  号:Cell Line CV32
  • 产  地:北京
点击询问我要采购
 竭诚为您服务!
BioVector NTCC典型培养物保藏中心
联系人:Dr.Xu, Biovector NTCC Inc.

电话:400-800-2947 工作QQ:1843439339 (微信同号)

邮件:Biovector@163.com

手机:18901268599

地址:北京

已注册
 

细胞株Cell Lines


BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心

http://www.biovector.net

Email:biovector@163.com


ID   He We

AC   CVCL_0611

DR   CLO; CLO_0003673

DR   ATCC; CRL-1338

DI   NCIt; C118636; Stiff skin syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   HE-1

AC   CVCL_2922

DR   BioSample; SAMN03472777

DR   IFO; IFO50297

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 9,12

ST   D5S818: 10,13

ST   D7S820: 10

ST   TH01: 8,9

ST   TPOX: 8,9

ST   vWA: 14,16

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   HE-209

AC   CVCL_6E85

RX   PubMed=2423124;

RX   PubMed=6187748;

CC   Characteristics: Has a different growth rate at the permissive temperature (33 Celsius) than at the restrictive temperature (40 Celsius).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA209].

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_6E86 ! HE-SV

SX   Male

CA   Transformed cell line

//

ID   HE-LU (Rifkin)

AC   CVCL_3698

SY   HE-LU(Rifkin)

DR   CLO; CLO_0003700

DR   ATCC; CRL-7717

DR   BioSample; SAMN03471141

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7717; true.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 9,11

ST   D16S539: 11,12

ST   D5S818: 11

ST   D7S820: 8,11

ST   TH01: 7,9

ST   TPOX: 9,11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   HE-SK

AC   CVCL_3699

DR   CLO; CLO_0003717

DR   ATCC; CRL-7718

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7718; true.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 9,11

ST   D16S539: 11,12

ST   D5S818: 11

ST   D7S820: 8,11

ST   TH01: 7,9

ST   TPOX: 9,11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   HE-SV

AC   CVCL_6E86

RX   PubMed=2423124;

RX   PubMed=6187748;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_6E85 ! HE-209

SX   Male

CA   Transformed cell line

//

ID   HE12

AC   CVCL_0T75

DR   CLO; CLO_0050435

DR   BioSample; SAMN03472030

DR   RCB; RCB2233

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 8

ST   D16S539: 9

ST   D5S818: 13

ST   D7S820: 10,12

ST   TH01: 7,9

ST   TPOX: 8,9

ST   vWA: 16,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   HE13

AC   CVCL_0T76

DR   CLO; CLO_0050436

DR   BioSample; SAMN03472031

DR   RCB; RCB2234

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 8

ST   D16S539: 10,11

ST   D5S818: 10,11

ST   D7S820: 9,11

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 17

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   HE16

AC   CVCL_0T77

DR   CLO; CLO_0050437

DR   BioSample; SAMN03472032

DR   RCB; RCB2237

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 8,13

ST   D16S539: 10,12

ST   D5S818: 12

ST   D7S820: 11,12

ST   TH01: 6,9

ST   TPOX: 8,10

ST   vWA: 17,19

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   HE18

AC   CVCL_0T78

DR   CLO; CLO_0050438

DR   BioSample; SAMN03472033

DR   RCB; RCB2238

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10,13

ST   D13S317: 8

ST   D16S539: 9,12

ST   D5S818: 12

ST   D7S820: 11,12

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 17,19

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   HE19

AC   CVCL_0T79

DR   CLO; CLO_0050439

DR   BioSample; SAMN03471974

DR   RCB; RCB2239

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 11

ST   D16S539: 10,11

ST   D5S818: 12,13

ST   D7S820: 8,10

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   HE21

AC   CVCL_0T80

DR   CLO; CLO_0050440

DR   BioSample; SAMN03471975

DR   RCB; RCB2240

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8,11

ST   D16S539: 12

ST   D5S818: 12,13

ST   D7S820: 10

ST   TH01: 7,9

ST   TPOX: 9,10

ST   vWA: 17

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   HE22

AC   CVCL_0T81

DR   CLO; CLO_0050441

DR   BioSample; SAMN03471977

DR   RCB; RCB2241

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 8,9

ST   D16S539: 10

ST   D5S818: 10

ST   D7S820: 10

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 19

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   HE23

AC   CVCL_H257

RX   PubMed=9610031;

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   HE27

AC   CVCL_0T82

DR   CLO; CLO_0050442

DR   BioSample; SAMN03471978

DR   RCB; RCB2244

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8,11

ST   D16S539: 9,10

ST   D5S818: 10,12

ST   D7S820: 8

ST   TH01: 6,7

ST   TPOX: 11,12

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   HE28

AC   CVCL_0T83

DR   CLO; CLO_0050443

DR   BioSample; SAMN03471979

DR   RCB; RCB2245

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 9,12

ST   D16S539: 9,10

ST   D5S818: 10,11

ST   D7S820: 11

ST   TH01: 7,9

ST   TPOX: 8,9

ST   vWA: 16

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   HE29

AC   CVCL_0T84

DR   CLO; CLO_0050444

DR   BioSample; SAMN03471980

DR   RCB; RCB2246

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10,13

ST   D13S317: 8

ST   D16S539: 11

ST   D5S818: 9,11

ST   D7S820: 11

ST   TH01: 9,9.3

ST   TPOX: 8,9

ST   vWA: 14,17

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   HE30

AC   CVCL_0T85

DR   CLO; CLO_0050445

DR   BioSample; SAMN03471981

DR   RCB; RCB2247

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8

ST   D16S539: 9,12

ST   D5S818: 11,14

ST   D7S820: 8,12

ST   TH01: 9

ST   TPOX: 8,9

ST   vWA: 14,18

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   HE31

AC   CVCL_H258

DR   CLO; CLO_0050446

DR   BioSample; SAMN03471982

DR   RCB; RCB2248

RX   PubMed=9610031;

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 12

ST   D16S539: 9,11

ST   D5S818: 10,11

ST   D7S820: 8,10

ST   TH01: 6,9

ST   TPOX: 9,11

ST   vWA: 18,19

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   HE32

AC   CVCL_0T86

DR   CLO; CLO_0050447

DR   BioSample; SAMN03471983

DR   RCB; RCB2249

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 10,11

ST   D16S539: 10,13

ST   D5S818: 10,13

ST   D7S820: 11,12

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   HE33

AC   CVCL_0T87

DR   CLO; CLO_0050448

DR   BioSample; SAMN03471984

DR   RCB; RCB2250

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 11,12

ST   D16S539: 9,11

ST   D5S818: 12

ST   D7S820: 10,12

ST   TH01: 7,8

ST   TPOX: 8,11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   HE34

AC   CVCL_0T88

DR   CLO; CLO_0050449

DR   BioSample; SAMN03471985

DR   RCB; RCB2251

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11

ST   D16S539: 9,11

ST   D5S818: 11,13

ST   D7S820: 11

ST   TH01: 7,9

ST   TPOX: 8

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   HE36

AC   CVCL_0T89

DR   CLO; CLO_0050450

DR   BioSample; SAMN03471989

DR   RCB; RCB2254

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 11,12

ST   D16S539: 9

ST   D5S818: 12,13

ST   D7S820: 8,12

ST   TH01: 6,9

ST   TPOX: 9

ST   vWA: 16,17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   HE37

AC   CVCL_0T90

DR   CLO; CLO_0050451

DR   RCB; RCB2256

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   HE38

AC   CVCL_0T91

DR   CLO; CLO_0050452

DR   BioSample; SAMN03471990

DR   RCB; RCB2257

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 7,12

ST   D13S317: 11,13

ST   D16S539: 11,12

ST   D5S818: 9,10

ST   D7S820: 11,12

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   HE39

AC   CVCL_0T92

DR   CLO; CLO_0050453

DR   BioSample; SAMN03471991

DR   RCB; RCB2258

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8,9

ST   D16S539: 11,13

ST   D5S818: 12,15

ST   D7S820: 11,13

ST   TH01: 6,9

ST   TPOX: 9,11

ST   vWA: 14,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   HE40

AC   CVCL_H259

DR   CLO; CLO_0050454

DR   BioSample; SAMN03471992

DR   RCB; RCB2259

RX   PubMed=9610031;

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 9,12

ST   D16S539: 9,12

ST   D5S818: 12

ST   D7S820: 8,10

ST   TH01: 8,9

ST   TPOX: 8

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   HE41

AC   CVCL_0T93

DR   CLO; CLO_0050456

DR   BioSample; SAMN03471993

DR   RCB; RCB2260

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 8,11

ST   D16S539: 9,12

ST   D5S818: 11

ST   D7S820: 11

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 14,18

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   HE42

AC   CVCL_0T94

DR   CLO; CLO_0050457

DR   BioSample; SAMN03471994

DR   RCB; RCB2261

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 9

ST   D16S539: 9

ST   D5S818: 12,13

ST   D7S820: 8,10

ST   TH01: 6,7

ST   TPOX: 11

ST   vWA: 14,16

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   HE46

AC   CVCL_0T95

DR   CLO; CLO_0050455

DR   BioSample; SAMN03471995

DR   RCB; RCB2262

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 9,12

ST   D13S317: 8,9

ST   D16S539: 9,11

ST   D5S818: 12,13

ST   D7S820: 10,11

ST   TH01: 6,9

ST   TPOX: 8,11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   HE47

AC   CVCL_0T96

DR   CLO; CLO_0050458

DR   BioSample; SAMN03471996

DR   RCB; RCB2263

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 9,11

ST   D5S818: 11

ST   D7S820: 10,12

ST   TH01: 6,9

ST   TPOX: 11

ST   vWA: 17

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   HE48

AC   CVCL_0T97

DR   CLO; CLO_0050459

DR   BioSample; SAMN03471997

DR   RCB; RCB2264

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11

ST   D16S539: 9,11

ST   D5S818: 12,13

ST   D7S820: 8,9

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 14,20

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   HE49

AC   CVCL_0T98

DR   CLO; CLO_0050460

DR   BioSample; SAMN03471998

DR   RCB; RCB2265

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 9,10

ST   D16S539: 10

ST   D5S818: 10,12

ST   D7S820: 10,11

ST   TH01: 8,9

ST   TPOX: 10,11

ST   vWA: 14,18

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   HE50

AC   CVCL_0T99

DR   CLO; CLO_0050466

DR   BioSample; SAMN03472000

DR   RCB; RCB2266

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 10,12

ST   D16S539: 11

ST   D5S818: 11,12

ST   D7S820: 8,9

ST   TH01: 9

ST   TPOX: 8,9

ST   vWA: 17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   HE51

AC   CVCL_0U00

DR   CLO; CLO_0050461

DR   BioSample; SAMN03472001

DR   RCB; RCB2267

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 9,12

ST   D16S539: 9,12

ST   D5S818: 11,13

ST   D7S820: 10,12

ST   TH01: 6,8

ST   TPOX: 8

ST   vWA: 14

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   HE52

AC   CVCL_0U01

DR   CLO; CLO_0050462

DR   BioSample; SAMN03472002

DR   RCB; RCB2268

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,12

ST   D16S539: 12

ST   D5S818: 9,13

ST   D7S820: 11

ST   TH01: 6,7

ST   TPOX: 11,12

ST   vWA: 14,18

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   HE53

AC   CVCL_0U02

DR   CLO; CLO_0050463

DR   BioSample; SAMN03472003

DR   RCB; RCB2269

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8,13

ST   D16S539: 9,10

ST   D5S818: 9,10

ST   D7S820: 10,12

ST   TH01: 6,9

ST   TPOX: 8,11

ST   vWA: 16,17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   HE54

AC   CVCL_0U03

DR   CLO; CLO_0050467

DR   BioSample; SAMN03471944

DR   RCB; RCB2270

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8

ST   D16S539: 9,13

ST   D5S818: 11,13

ST   D7S820: 9,11

ST   TH01: 7

ST   TPOX: 8,9

ST   vWA: 14

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   HE55

AC   CVCL_0U04

DR   CLO; CLO_0050464

DR   BioSample; SAMN03471945

DR   RCB; RCB2271

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 9,10

ST   D13S317: 8

ST   D16S539: 9

ST   D5S818: 12

ST   D7S820: 10

ST   TH01: 6,9

ST   TPOX: 11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   HE57

AC   CVCL_0U05

DR   CLO; CLO_0050465

DR   BioSample; SAMN03471946

DR   RCB; RCB2273

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 11

ST   D16S539: 9

ST   D5S818: 10,12

ST   D7S820: 11

ST   TH01: 7,9

ST   TPOX: 8,10

ST   vWA: 14

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   HeB5

AC   CVCL_S549

DR   ECACC; 11033104

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Breed/subspecies: C57L.

DI   NCIt; C38756; Hepatocellular carcinoma of the mouse

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0328 ! Hepa-1c1c7

SX   Female

CA   Cancer cell line

//

ID   HEC

AC   CVCL_N814

DR   Cosmic; 735332

DR   Cosmic; 1656050

RX   PubMed=15274292;

RX   PubMed=22426987;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   HEC-1

AC   CVCL_1274

SY   HEC1; Human Endometrial Cancer-1

DR   BioSample; SAMN03472810

DR   ChEMBL-Cells; CHEMBL3308740

DR   ChEMBL-Targets; CHEMBL1075462

DR   Cosmic; 907051

DR   Cosmic-CLP; 907051

DR   GDSC; 907051

DR   GEO; GSM827285

DR   GEO; GSM1669873

DR   JCRB; JCRB0042

DR   LINCS; 50014

RX   PubMed=4673779;

RX   PubMed=4678779;

RX   PubMed=9290701;

RX   PubMed=12227503;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Instable (MSI-high) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): Cosmic-CLP; JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11,16 (Cosmic-CLP)

ST   D13S317: 11 (JCRB)

ST   D16S539: 11,12

ST   D5S818: 11,13

ST   D7S820: 11

ST   TH01: 6,7

ST   TPOX: 11

ST   vWA: 18

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   HEC-1-A

AC   CVCL_0293

SY   Hec-1-A; HEC-1A; HEC1-A; HEC1A; Hec1A

DR   BTO; BTO:0002960

DR   CLO; CLO_0003674

DR   EFO; EFO_0002191

DR   MCCL; MCC:0000183

DR   ATCC; HTB-112

DR   BCRC; 60552

DR   BioSample; SAMN03471093

DR   BioSample; SAMN03472456

DR   CCLE; HEC1A_ENDOMETRIUM

DR   CCRID; 3131C0001000700149

DR   Cosmic; 713474

DR   Cosmic; 713494

DR   Cosmic; 724853

DR   Cosmic; 809130

DR   Cosmic; 846177

DR   Cosmic; 871552

DR   Cosmic; 889115

DR   Cosmic; 1007160

DR   Cosmic; 1066222

DR   Cosmic; 1177620

DR   Cosmic; 1177685

DR   Cosmic; 1576457

DR   Cosmic; 1594188

DR   Cosmic; 1622896

DR   Cosmic; 2030464

DR   Cosmic; 2301550

DR   Cosmic; 2464665

DR   GEO; GSM844555

DR   GEO; GSM844556

DR   GEO; GSM887069

DR   GEO; GSM888139

DR   IGRhCellID; HEC1A

DR   JCRB; JCRB1117

DR   JCRB; NIHS0388

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=7459858;

RX   PubMed=12227503;

RX   PubMed=22460905;

RX   PubMed=22710073;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=28196595;

WW   http://www.identicell.eu/files/Sample-IdentiCell-report.pdf

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: PI3K genetic alteration cell panel (ATCC TCP-1028).

CC   Doubling time: 27 hours (PubMed=25984343).

CC   Omics: Deep RNAseq analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: JCRB; NIHS0388; true.

ST   Source(s): ATCC; IdentiCell; JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,12 (ATCC; IdentiCell)

ST   CSF1PO: 10,13,14 (JCRB)

ST   D13S317: 11,12 (ATCC)

ST   D13S317: 9,11,14 (IdentiCell)

ST   D13S317: 11 (JCRB)

ST   D16S539: 12,13 (ATCC; JCRB)

ST   D16S539: 12 (IdentiCell)

ST   D21S11: 30,31

ST   D5S818: 11,14,15 (ATCC)

ST   D5S818: 11,15 (IdentiCell; JCRB)

ST   D7S820: 9,11

ST   TH01: 6,7

ST   TPOX: 8,11 (ATCC; IdentiCell)

ST   TPOX: 8,9,11 (JCRB)

ST   vWA: 18,19 (ATCC)

ST   vWA: 18,19,20 (IdentiCell)

ST   vWA: 19,20,22 (JCRB)

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1274 ! HEC-1

SX   Female

CA   Cancer cell line

//

ID   HEC-1-A-OZA1

AC   CVCL_AR90

DR   BioSample; SAMN03472374

DR   JCRB; NIHS0388.1

CC   Discontinued: JCRB; NIHS0388.1; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,13

ST   D13S317: 11,13

ST   D16S539: 13

ST   D5S818: 11,13,16

ST   D7S820: 9,11

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 19,24

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0293 ! HEC-1-A

SX   Female

CA   Cancer cell line

//

ID   HEC-1-A-OZA2

AC   CVCL_AR91

DR   BioSample; SAMN03472376

DR   JCRB; NIHS0388.2

CC   Discontinued: JCRB; NIHS0388.2; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,13

ST   D13S317: 11,13

ST   D16S539: 12,13

ST   D5S818: 11,12,16

ST   D7S820: 9,11

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 19,24

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0293 ! HEC-1-A

SX   Female

CA   Cancer cell line

//

ID   HEC-1-A-OZA3

AC   CVCL_AR92

DR   BioSample; SAMN03472377

DR   JCRB; NIHS0388.3

CC   Discontinued: JCRB; NIHS0388.3; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,11,13

ST   D13S317: 11,12

ST   D16S539: 12,13

ST   D5S818: 11,15

ST   D7S820: 9,11

ST   TH01: 6,7

ST   TPOX: 9,11

ST   vWA: 19,22

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0293 ! HEC-1-A

SX   Female

CA   Cancer cell line

//

ID   HEC-1-A-OZA4

AC   CVCL_AR93

DR   BioSample; SAMN03472378

DR   JCRB; NIHS0388.4

CC   Discontinued: JCRB; NIHS0388.4; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,13

ST   D13S317: 11,12

ST   D16S539: 12,13

ST   D5S818: 11,15

ST   D7S820: 9,11

ST   TH01: 6,7

ST   TPOX: 9,11

ST   vWA: 19,22

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0293 ! HEC-1-A

SX   Female

CA   Cancer cell line

//

ID   HEC-1-A-OZA5

AC   CVCL_AR94

DR   BioSample; SAMN03472379

DR   JCRB; NIHS0388.5

CC   Discontinued: JCRB; NIHS0388.5; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,13

ST   D13S317: 11,12,15

ST   D16S539: 12,13

ST   D5S818: 11,12,16

ST   D7S820: 9,11

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 19,24

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0293 ! HEC-1-A

SX   Female

CA   Cancer cell line

//

ID   HEC-1-A-OZA6

AC   CVCL_AR95

DR   BioSample; SAMN03472380

DR   JCRB; NIHS0388.6

CC   Discontinued: JCRB; NIHS0388.6; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,11,14

ST   D13S317: 11,12

ST   D16S539: 12,13

ST   D5S818: 11,15

ST   D7S820: 9,11

ST   TH01: 6,7,8

ST   TPOX: 8,11

ST   vWA: 19,25

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0293 ! HEC-1-A

SX   Female

CA   Cancer cell line

//

ID   HEC-1-B

AC   CVCL_0294

SY   Hec-1-B; HEC-1B; HEC1-B; HEC1B; Hec1B

DR   BTO; BTO:0003038

DR   CLO; CLO_0003675

DR   EFO; EFO_0002192

DR   MCCL; MCC:0000184

DR   CLDB; cl1582

DR   ATCC; HTB-113

DR   BioSample; SAMN03471094

DR   BioSample; SAMN03472427

DR   BioSample; SAMN03473077

DR   CCLE; HEC1B_ENDOMETRIUM

DR   CCRID; 3111C0001CCC000105

DR   CCRID; 3131C0001000700115

DR   CCRID; 3142C0001000000100

DR   ChEMBL-Cells; CHEMBL3308662

DR   ChEMBL-Targets; CHEMBL614817

DR   Cosmic; 687552

DR   Cosmic; 809131

DR   Cosmic; 846178

DR   Cosmic; 980635

DR   Cosmic; 1070807

DR   Cosmic; 1177621

DR   Cosmic; 1223486

DR   Cosmic; 1241345

DR   Cosmic; 1576458

DR   Cosmic; 1696757

DR   Cosmic; 2030465

DR   GEO; GSM844557

DR   GEO; GSM887070

DR   GEO; GSM888140

DR   IGRhCellID; HEC1B

DR   JCRB; JCRB1193

DR   JCRB; NIHS0480

DR   KCB; KCB 200551YJ

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=6163305;

RX   PubMed=6174649;

RX   PubMed=12227503;

RX   PubMed=22460905;

RX   PubMed=22710073;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: JCRB; NIHS0480; true.

ST   Source(s): ATCC; JCRB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11,16 (ATCC)

ST   D13S317: 11 (JCRB; PubMed=25877200)

ST   D16S539: 11,12

ST   D18S51: 16,20

ST   D21S11: 30,31

ST   D3S1358: 15

ST   D5S818: 11,13

ST   D7S820: 9,11

ST   D8S1179: 13,14

ST   FGA: 21

ST   Penta D: 9,13

ST   Penta E: 11

ST   TH01: 6,7 (ATCC; JCRB)

ST   TH01: 6 (PubMed=25877200)

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0293 ! HEC-1-A

SX   Female

CA   Cancer cell line

//

ID   HEC-108

AC   CVCL_2923

SY   HEC108

DR   BioSample; SAMN03470971

DR   BioSample; SAMN03472459

DR   CCLE; HEC108_ENDOMETRIUM

DR   Cosmic; 1223494

DR   Cosmic; 1241342

DR   Cosmic; 1696755

DR   Cosmic; 2030466

DR   GEO; GSM887067

DR   GEO; GSM888137

DR   JCRB; JCRB1123

DR   JCRB; NIHS0394

RX   DOI=10.5795/jjscc.26.433;

RX   PubMed=22460905;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: JCRB; NIHS0394; true.

ST   Source(s): JCRB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 9,10,11 (JCRB)

ST   D13S317: 9,10,11,12,13 (PubMed=25877200)

ST   D16S539: 12,13 (JCRB)

ST   D16S539: 11,12,13 (PubMed=25877200)

ST   D18S51: 11,12,13

ST   D19S433: 11.2,12.2,14.2,15.2,16.2

ST   D21S11: 29,30,31

ST   D2S1338: 16,17,19,20

ST   D3S1358: 15,16,17

ST   D5S818: 6,12 (JCRB)

ST   D5S818: 12 (PubMed=25877200)

ST   D7S820: 8,9,12

ST   D8S1179: 11,13

ST   FGA: 22,23

ST   Penta D: 8,9,10

ST   Penta E: 15,19,20

ST   TH01: 8,9

ST   TPOX: 11,12 (JCRB)

ST   TPOX: 11 (PubMed=25877200)

ST   vWA: 15,16,17

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   HEC-116

AC   CVCL_2924

SY   HEC116

DR   BioSample; SAMN03470936

DR   Cosmic; 1223495

DR   Cosmic; 1696748

DR   Cosmic; 2030467

DR   JCRB; JCRB1124

DR   JCRB; NIHS0395

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Discontinued: JCRB; NIHS0395; true.

ST   Source(s): JCRB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 8,11

ST   D16S539: 9

ST   D18S51: 17,25

ST   D19S433: 14,16.2

ST   D21S11: 29

ST   D2S1338: 20,21

ST   D3S1358: 17

ST   D5S818: 11,12

ST   D7S820: 10,12

ST   D8S1179: 14

ST   FGA: 23,25

ST   Penta D: 12,13

ST   Penta E: 14,18

ST   TH01: 6,8

ST   TPOX: 11

ST   vWA: 20

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   HEC-151

AC   CVCL_2925

SY   HEC151

DR   BioSample; SAMN03470938

DR   CCLE; HEC151_ENDOMETRIUM

DR   Cosmic; 1696754

DR   Cosmic; 2030468

DR   GEO; GSM887068

DR   GEO; GSM888138

DR   JCRB; JCRB1122

DR   JCRB; NIHS0396

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: JCRB; NIHS0396; true.

ST   Source(s): JCRB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 7,11

ST   D13S317: 8,13,14

ST   D16S539: 9,11

ST   D18S51: 13,23,24

ST   D19S433: 13,14

ST   D21S11: 30

ST   D2S1338: 19,20,24

ST   D3S1358: 14,15

ST   D5S818: 10,13,14

ST   D7S820: 8,11

ST   D8S1179: 12,13

ST   FGA: 19.1,22,23,24

ST   Penta D: 8.4,9,10

ST   Penta E: 13,14,19

ST   TH01: 6,9

ST   TPOX: 8,11

ST   vWA: 14,19

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   HEC-155

AC   CVCL_2926

DR   BioSample; SAMN03151656

DR   BioSample; SAMN03472460

DR   JCRB; JCRB1127

DR   JCRB; NIHS0397

RX   PubMed=15285295;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. HEC-155 and HEC-180 have been shown to be idnetical (PubMed=20143388).

CC   Discontinued: JCRB; JCRB1127; true.

CC   Discontinued: JCRB; NIHS0397; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 9,13,14

ST   D13S317: 8

ST   D16S539: 12

ST   D5S818: 10,11

ST   D7S820: 8,11

ST   TH01: 7

ST   TPOX: 9,12

ST   vWA: 14

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_8313 ! HEC-180

SX   Female

CA   Cancer cell line

//

ID   HEC-180

AC   CVCL_8313

DR   BioSample; SAMN03151655

DR   JCRB; JCRB1144

DR   JCRB; NIHS0398

RX   PubMed=15285295;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. HEC-155 and HEC-180 have been shown to be idnetical (PubMed=20143388).

CC   Discontinued: JCRB; JCRB1144; true.

CC   Discontinued: JCRB; NIHS0398; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 9,13,14

ST   D13S317: 8

ST   D16S539: 12

ST   D5S818: 10,11

ST   D7S820: 8,11

ST   TH01: 7

ST   TPOX: 9,12

ST   vWA: 14

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2926 ! HEC-155

SX   Female

CA   Cancer cell line

//

ID   HEC-1C

AC   CVCL_S835

SY   HEC-1 C; HEC-IC

RX   PubMed=6299971;

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1274 ! HEC-1

SX   Female

CA   Cancer cell line

//

ID   HEC-1D

AC   CVCL_S836

SY   HEC-1 D; HEC-ID

RX   PubMed=6299971;

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1274 ! HEC-1

SX   Female

CA   Cancer cell line

//

ID   HEC-251

AC   CVCL_2927

SY   HEC251

DR   BioSample; SAMD00048820

DR   BioSample; SAMN03470931

DR   CCLE; HEC251_ENDOMETRIUM

DR   Cosmic; 2030469

DR   GEO; GSM887071

DR   GEO; GSM888141

DR   JCRB; JCRB1141

RX   PubMed=15171304;

RX   PubMed=22460905;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): JCRB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 9,11

ST   D13S317: 11

ST   D16S539: 9

ST   D18S51: 13,20

ST   D19S433: 14,15

ST   D21S11: 30,31.2

ST   D2S1338: 16,19

ST   D3S1358: 15,16

ST   D5S818: 9,12

ST   D7S820: 11

ST   D8S1179: 10,13

ST   FGA: 20,21

ST   Penta D: 9,10

ST   Penta E: 5,15

ST   TH01: 7

ST   TPOX: 8,11

ST   vWA: 14

DI   NCIt; C7558; Endometrial carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   HEC-265

AC   CVCL_2928

SY   HEC265

DR   BioSample; SAMD00048821

DR   BioSample; SAMN03470883

DR   CCLE; HEC265_ENDOMETRIUM

DR   Cosmic; 2030470

DR   GEO; GSM887072

DR   GEO; GSM888142

DR   JCRB; JCRB1142

DR   JCRB; NIHS0400

RX   PubMed=15171304;

RX   PubMed=22460905;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: JCRB; NIHS0400; true.

ST   Source(s): JCRB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 11

ST   D18S51: 15,18

ST   D19S433: 14,16.2

ST   D21S11: 30

ST   D2S1338: 22,24

ST   D3S1358: 14,15

ST   D5S818: 10,12

ST   D7S820: 10,11

ST   D8S1179: 14,15,16

ST   FGA: 20,22,23

ST   Penta D: 9

ST   Penta E: 14,16

ST   TH01: 9

ST   TPOX: 9,11

ST   vWA: 19,22

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   HEC-46

AC   CVCL_T734

SY   HEC-46R1; HEC46

DR   JCRB; NIHS0258

RX   PubMed=8242641;

CC   Discontinued: JCRB; NIHS0258; true.

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HEC-50B

AC   CVCL_2929

SY   HEC50B; HEC-50; HEC50; Hec50

DR   BioSample; SAMN03470885

DR   CCLE; HEC50B_ENDOMETRIUM

DR   Cosmic; 1223491

DR   Cosmic; 1576459

DR   Cosmic; 1696760

DR   Cosmic; 2030471

DR   GEO; GSM887073

DR   GEO; GSM888143

DR   JCRB; JCRB1145

DR   JCRB; NIHS0391

RX   PubMed=22460905;

RX   PubMed=22710073;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: JCRB; NIHS0391; true.

ST   Source(s): JCRB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 9

ST   D16S539: 12

ST   D18S51: 14

ST   D19S433: 13

ST   D21S11: 30,31

ST   D2S1338: 23

ST   D3S1358: 15,16

ST   D5S818: 8

ST   D7S820: 12

ST   D8S1179: 10,15

ST   FGA: 20

ST   Penta D: 10

ST   Penta E: 5

ST   TH01: 9

ST   TPOX: 9

ST   vWA: 14

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   HEC-59

AC   CVCL_2930

SY   HEC59; Hec59

DR   BioSample; SAMN03472458

DR   BioSample; SAMN03470882

DR   CCLE; HEC59_ENDOMETRIUM

DR   Cosmic; 1070806

DR   Cosmic; 1223492

DR   Cosmic; 1576460

DR   Cosmic; 1622901

DR   Cosmic; 1696750

DR   Cosmic; 2030472

DR   GEO; GSM887074

DR   GEO; GSM888144

DR   JCRB; JCRB1120

DR   JCRB; NIHS0392

RX   DOI=10.5795/jjscc.26.433;

RX   PubMed=9000572;

RX   PubMed=12227503;

RX   PubMed=22460905;

RX   PubMed=28196595;

WW   http://www.addexbio.com/productdetail?pid=42

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: JCRB; NIHS0392; true.

ST   Source(s): JCRB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 9,10

ST   D13S317: 9,10,11

ST   D16S539: 11,12,13

ST   D18S51: 12,13

ST   D19S433: 12,13

ST   D21S11: 29,32

ST   D2S1338: 15,16

ST   D3S1358: 13,14,16,17

ST   D5S818: 10,11,12

ST   D7S820: 10,11,14

ST   D8S1179: 12,15

ST   FGA: 21,22,23

ST   Penta D: 9,10,11

ST   Penta E: 15,16

ST   TH01: 7,9.3

ST   TPOX: 11,14 (JCRB)

ST   TPOX: 11 (PubMed=25877200)

ST   vWA: 17,20,22

DI   NCIt; C7558; Endometrial carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   HEC-6

AC   CVCL_2931

SY   HEC6

DR   BioSample; SAMN03470939

DR   BioSample; SAMN03472457

DR   CCLE; HEC6_ENDOMETRIUM

DR   Cosmic; 1223490

DR   Cosmic; 1696749

DR   Cosmic; 2030473

DR   GEO; GSM887075

DR   GEO; GSM888145

DR   JCRB; JCRB1118

DR   JCRB; NIHS0390

RX   PubMed=862644;

RX   PubMed=22460905;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: JCRB; NIHS0390; true.

ST   Source(s): JCRB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 9,10,13

ST   D13S317: 11,12

ST   D16S539: 8,10

ST   D18S51: 12,13

ST   D19S433: 14

ST   D21S11: 27.2,29

ST   D2S1338: 21,23

ST   D3S1358: 16,17

ST   D5S818: 13,14,15

ST   D7S820: 8,9,11 (JCRB)

ST   D7S820: 8,9,11,12 (PubMed=25877200)

ST   D8S1179: 9,10,12

ST   FGA: 20,21,22

ST   Penta D: 10

ST   Penta E: 14,15,17

ST   TH01: 6,9,10 (JCRB)

ST   TH01: 6,10 (PubMed=25877200)

ST   TPOX: 8,9,10

ST   vWA: 16,18

DI   NCIt; C6290; Endometrial endometrioid adenocarcinoma, variant with squamous differentiation

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   HEC-88nu

AC   CVCL_2932

SY   HEC-88 nu; HEC88nu; HEC88NU; HEC-88

DR   BioSample; SAMN03470941

DR   Cosmic; 1223493

DR   Cosmic; 1696751

DR   JCRB; JCRB1121

DR   JCRB; NIHS0393

RX   DOI=10.5795/jjscc.26.433;

RX   PubMed=12227503;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Discontinued: JCRB; NIHS0393; true.

ST   Source(s): JCRB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 9,11

ST   D13S317: 8,13

ST   D16S539: 11

ST   D18S51: 14,16,17

ST   D19S433: 13

ST   D21S11: 29,31.2

ST   D2S1338: 19,23

ST   D3S1358: 15,17

ST   D5S818: 11,12

ST   D7S820: 11

ST   D8S1179: 13,16

ST   FGA: 21,22

ST   Penta D: 9,12

ST   Penta E: 5,15

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 18,19

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Hec50Co

AC   CVCL_4Y59

SY   HEC-50CO

DR   Cosmic; 1393157

RX   PubMed=11830547;

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2929 ! HEC-50B

SX   Female

CA   Cancer cell line

//

ID   HECA-452

AC   CVCL_4577

DR   CLO; CLO_0003676

DR   ATCC; HB-11485

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Hybridoma

//

ID   HECV

AC   CVCL_0295

DR   CLO; CLO_0003677

DR   MCCL; MCC:0000185

DR   CLDB; cl5543

DR   ICLC; HL01001

ST   Source(s): ICLC

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 9

ST   D21S11: 29

ST   D5S818: 10

ST   D7S820: 10,11

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   HEEM

AC   CVCL_M603

RX   PubMed=857824;

DI   NCIt; C2946; Chondrosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   HEFX

AC   CVCL_9837

SY   HEFX1; HUJIe001-A

DR   hPSCreg; HUJIe001-A

DR   ISCR; 1766

RX   PubMed=18371394;

CC   From: Hebrew University; Jerusalem; Israel.

DI   NCIt; C84717; Fragile X syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   HEI-OC1

AC   CVCL_D899

SY   HEIOC1; House Ear Institute-Organ of Corti 1

DR   BTO; BTO:0004862

DR   Wikidata; Q27653205

RX   PubMed=12811000;

RX   PubMed=26854618;

RX   PubMed=26930622;

WW   http://www.molmeth.org/protocol/culturing-hei-oc1

CC   Characteristics: Growth at the permissive (33 Celsius) temperature results in dedifferentiation of the cells and accelerated proliferation. At the restrictive temperature (39 Celsius) cell proliferation halts in about 48h.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   HEI193

AC   CVCL_7670

SY   HEI-193

DR   BTO; BTO:0005037

DR   ATCC; PTA-4544

RX   PubMed=11836557;

RX   PubMed=17868749;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

CC   Discontinued: ATCC; PTA-4544; true.

DI   NCIt; C3269; Schwannoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   HEK

AC   CVCL_M624

SY   Human Embryonic Kidney; HEK-1; HEK-RLV

DR   BioSample; SAMN03151703

RX   CelloPub=CLPUB00339;

RX   PubMed=1246601;

RX   PubMed=4137948;

RX   PubMed=4469665;

RX   PubMed=4621398;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601, PubMed=4469665, PubMed=20143388). Was originally thought to originate from an embryonic kidney.

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

CC   Caution: Not to be confused with cell line HEK293 (CVCL_0045).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0030 ! HeLa

SX   Female

CA   Cancer cell line

//

ID   HEK 293 STF

AC   CVCL_AQ26

SY   STF; Super TOP-FLASH

DR   ATCC; CRL-3249

RX   PubMed=15035989;

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK 293 Tet-Off

AC   CVCL_V349

WW   http://www.clontech.com/US/Products/Inducible_Systems/Tetracycline-Inducible_Expression/Tet-Off_Cell_Lines

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK 293 Tet-On 3G

AC   CVCL_V350

DR   BTO; BTO:0003347

WW   http://www.clontech.com/US/Products/Inducible_Systems/Tetracycline-Inducible_Expression/Tet-On_3G_Cell_Lines

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK 293 tTS

AC   CVCL_V351

WW   http://www.clontech.com/US/Products/Inducible_Systems/Tetracycline-Inducible_Expression/Tet-tTS_Cell_Lines

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK/HRV

AC   CVCL_M625

DR   BioSample; SAMN03151704

RX   PubMed=1246601;

RX   PubMed=4469665;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Parent cell line (HEK) has been shown to be a HeLa derivative (PubMed=1246601, PubMed=4469665, PubMed=20143388).

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_M624 ! HEK

SX   Female

CA   Cancer cell line

//

ID   HEK-293-Munc18b

AC   CVCL_GR68

SY   HEK-Munc18b18

DR   TOKU-E; 4146

RX   PubMed=19723587;

CC   Transfected with: HGNC; 11445; STXBP2.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK-293-TrkB

AC   CVCL_9868

SY   HEK-TrkB; HEK293-TrkB

DR   BTO; BTO:0005025

CC   Transfected with: HGNC; 8032; NTRK2.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK-293.2sus

AC   CVCL_4W07

DR   ATCC; CRL-1573.3

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12,14

ST   D16S539: 9,13

ST   D5S818: 8

ST   D7S820: 11,12

ST   TH01: 7,9.3

ST   TPOX: 11

ST   vWA: 16,19

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK-293B1

AC   CVCL_W457

RX   PubMed=10952671;

CC   Transfected with: HGNC; 285; ADRB1.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK-293B2

AC   CVCL_9869

SY   293-B2; HEK293B2

DR   BTO; BTO:0003468

RX   PubMed=10952671;

CC   Transfected with: HGNC; 286; ADRB2.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK-293CymR

AC   CVCL_9870

SY   QBI-HEK 293CymR; QBI-HEK 293-CymR; QBI-HEK293CymR; 293-CymR

DR   BTO; BTO:0002732

RX   PubMed=17083727;

WW   http://www.my-whiteboard.com/qbiogene-q-mate-inducible-expression-system/

CC   Transfected with: UniProtKB; O33453; P.putida cymR.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK-3KO

AC   CVCL_HB82

SY   IP3R Null HEK-293

RX   PubMed=27048566;

WW   https://www.kerafast.com/product/2962/ip3r-expressing-hek-293-cell-lines

CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 6180; ITPR1.

CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 6181; ITPR2.

CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 6182; ITPR3.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK-Blue hMD2-CD14

AC   CVCL_IM95

WW   http://www.invivogen.com/hek-blue-hmd2-cd14

CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IL-12 p40 minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.

CC   Transfected with: HGNC; 439; ALPP.

CC   Transfected with: HGNC; 1628; CD14.

CC   Transfected with: HGNC; 17156; LY96.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK-Blue hTLR2

AC   CVCL_IM80

WW   http://www.invivogen.com/hek-blue-htlr2

CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.

CC   Transfected with: HGNC; 439; ALPP.

CC   Transfected with: HGNC; 1628; CD14.

CC   Transfected with: HGNC; 11848; TLR2.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK-Blue hTLR3

AC   CVCL_IM81

WW   http://www.invivogen.com/hek-blue-htlr3

CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.

CC   Transfected with: HGNC; 439; ALPP.

CC   Transfected with: HGNC; 11849; TLR3.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK-Blue hTLR4

AC   CVCL_IM82

WW   http://www.invivogen.com/hek-blue-htlr4

CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IL-12 p40 minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.

CC   Transfected with: HGNC; 439; ALPP.

CC   Transfected with: HGNC; 1628; CD14.

CC   Transfected with: HGNC; 17156; LY96.

CC   Transfected with: HGNC; 11850; TLR4.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK-Blue hTLR5

AC   CVCL_IM83

WW   http://www.invivogen.com/hek-blue-htlr5

CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.

CC   Transfected with: HGNC; 439; ALPP.

CC   Transfected with: HGNC; 11851; TLR5.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK-Blue hTLR7

AC   CVCL_IM84

WW   http://www.invivogen.com/hek-blue-htlr7

CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.

CC   Transfected with: HGNC; 439; ALPP.

CC   Transfected with: HGNC; 15631; TLR7.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK-Blue hTLR8

AC   CVCL_IM85

WW   http://www.invivogen.com/hek-blue-htlr8

CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.

CC   Transfected with: HGNC; 439; ALPP.

CC   Transfected with: HGNC; 15632; TLR8.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK-Blue hTLR9

AC   CVCL_IM86

WW   http://www.invivogen.com/hek-blue-htlr9

CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.

CC   Transfected with: HGNC; 439; ALPP.

CC   Transfected with: HGNC; 15633; TLR9.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK-Blue KD-TLR5

AC   CVCL_5I78

WW   http://www.invivogen.com/hek-blue-kd-tlr5

CC   Knockout cell: Method=shRNA knockdown; HGNC; 11851; TLR5.

CC   Transfected with: HGNC; 439; ALPP.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK-Blue mTLR13

AC   CVCL_IM94

WW   http://www.invivogen.com/hek-blue-tlr13

CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.

CC   Transfected with: MGI; MGI:3045213; Tlr13.

CC   Transfected with: HGNC; 439; ALPP.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK-Blue mTLR2

AC   CVCL_IM87

WW   http://www.invivogen.com/hek-blue-mtlr2

CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IL12 p40 minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.

CC   Transfected with: MGI; MGI:88318; Cd14.

CC   Transfected with: MGI; MGI:1346060; Tlr2.

CC   Transfected with: HGNC; 439; ALPP.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK-Blue mTLR3

AC   CVCL_IM88

WW   http://www.invivogen.com/hek-blue-mtlr3

CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.

CC   Transfected with: MGI; MGI:2156367; Tlr3.

CC   Transfected with: HGNC; 439; ALPP.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK-Blue mTLR4

AC   CVCL_IM89

WW   http://www.invivogen.com/hek-blue-mtlr4

CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.

CC   Transfected with: MGI; MGI:88318; Cd14.

CC   Transfected with: MGI; MGI:1341909; Ly96.

CC   Transfected with: MGI; MGI:96824; Tlr4.

CC   Transfected with: HGNC; 439; ALPP.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK-Blue mTLR5

AC   CVCL_IM90

WW   http://www.invivogen.com/hek-blue-mtlr5

CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.

CC   Transfected with: MGI; MGI:1858171; Tlr5.

CC   Transfected with: HGNC; 439; ALPP.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK-Blue mTLR7

AC   CVCL_IM91

WW   http://www.invivogen.com/hek-blue-mtlr7

CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IL12 p40 minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.

CC   Transfected with: MGI; MGI:2176882; Tlr7.

CC   Transfected with: HGNC; 439; ALPP.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK-Blue mTLR8

AC   CVCL_IM92

WW   http://www.invivogen.com/hek-blue-mtlr8

CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.

CC   Transfected with: MGI; MGI:2176887; Tlr8.

CC   Transfected with: HGNC; 439; ALPP.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK-Blue mTLR9

AC   CVCL_IM93

WW   http://www.invivogen.com/hek-blue-mtlr9

CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.

CC   Transfected with: MGI; MGI:1932389; Tlr9.

CC   Transfected with: HGNC; 439; ALPP.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK-CaSR

AC   CVCL_E339

SY   CaSR; CaSR-HEK

WW   http://www.addexbio.com/productdetail?pid=88

CC   Transfected with: HGNC; 1514; CASR.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK-SC-293T

AC   CVCL_4U22

DR   ATCC; PTA-12593

RX   Patent=US8986991;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].

CC   Discontinued: ATCC; PTA-12593; probable.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0063 ! HEK293T

SX   Female

CA   Transformed cell line

//

ID   HEK-TERASB56gamma

AC   CVCL_D123

SY   TERV-AntiSenseB56

DR   EFO; EFO_0001250

RX   PubMed=14998489;

CC   Transfected with: HGNC; 11730; TERT.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Telomerase immortalized cell line

//

ID   HEK-TERST

AC   CVCL_D124

SY   TERV-ST

DR   EFO; EFO_0001251

RX   PubMed=11884599;

CC   Transfected with: HGNC; 11730; TERT.

CC   Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   HEK-TERST110

AC   CVCL_D125

SY   TERV-ST110

DR   EFO; EFO_0001252

RX   PubMed=11884599;

CC   Transfected with: HGNC; 11730; TERT.

CC   Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   HEK-TERV

AC   CVCL_D122

SY   TERV

DR   EFO; EFO_0001249

RX   PubMed=11884599;

CC   Transfected with: HGNC; 11730; TERT.

CC   Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   HEK-TLR2

AC   CVCL_IM79

DR   GEO; GSM618017

DR   GEO; GSM618018

DR   GEO; GSM618019

DR   GEO; GSM618020

DR   GEO; GSM618021

DR   GEO; GSM618022

DR   GEO; GSM618023

DR   GEO; GSM618024

DR   GEO; GSM618025

DR   GEO; GSM618026

DR   GEO; GSM618027

DR   GEO; GSM618028

DR   GEO; GSM618029

DR   GEO; GSM618030

DR   GEO; GSM618031

DR   GEO; GSM618032

DR   GEO; GSM618033

DR   GEO; GSM618034

DR   GEO; GSM618035

DR   GEO; GSM618036

RX   PubMed=21220698;

CC   Transfected with: HGNC; 11848; TLR2.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK001

AC   CVCL_3700

DR   CLO; CLO_0003678

DR   ATCC; CRL-2404

DR   BioSample; SAMN03471835

RX   PubMed=10664009;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (p1321)].

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 8

ST   D16S539: 12,13

ST   D5S818: 10,13

ST   D7S820: 12,13

ST   TH01: 6,9

ST   TPOX: 8,9

ST   vWA: 14

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   HEK1.1

AC   CVCL_2H48

RX   PubMed=21726526;

CC   Transfected with: HGNC; 10585; SCN1A.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK293

AC   CVCL_0045

SY   Hek293; HEK-293; HEK 293; HEK;293; 293; 293 HEK; Human Embryonic Kidney 293

DR   BTO; BTO:0000007

DR   CLO; CLO_0001230

DR   CLO; CLO_0050903

DR   EFO; EFO_0001182

DR   MCCL; MCC:0000006

DR   CLDB; cl45

DR   CLDB; cl46

DR   CLDB; cl47

DR   CLDB; cl7133

DR   ATCC; CRL-1573

DR   ATCC; PTA-4488

DR   BCRC; 60019

DR   BCRJ; 0009

DR   BioSample; SAMN03471398

DR   BioSample; SAMN03473347

DR   BioSamples; SAMEA2018185

DR   CCLV; CCLV-RIE 0197

DR   CCRID; 3111C0001CCC000010

DR   CCRID; 3111C0002000000005

DR   CCRID; 3131C0001000200001

DR   CCRID; 3131C0001000200018

DR   ChEMBL-Cells; CHEMBL3307715

DR   ChEMBL-Targets; CHEMBL614818

DR   CLS; 300192/p777_HEK293

DR   Cosmic; 2520629

DR   DSMZ; ACC-305

DR   ECACC; 85120602

DR   ENCODE; ENCBS022BLS

DR   ENCODE; ENCBS209KHO

DR   ENCODE; ENCBS264HQL

DR   ENCODE; ENCBS375ENC

DR   ENCODE; ENCBS393ENC

DR   ENCODE; ENCBS421ENC

DR   ENCODE; ENCBS439ENC

DR   ENCODE; ENCBS479AAA

DR   ENCODE; ENCBS480AAA

DR   ENCODE; ENCBS481AAA

DR   ENCODE; ENCBS482AAA

DR   ENCODE; ENCBS483AAA

DR   ENCODE; ENCBS484AAA

DR   ENCODE; ENCBS486AAA

DR   ENCODE; ENCBS522ENC

DR   ENCODE; ENCBS523ENC

DR   ENCODE; ENCBS613RZL

DR   ENCODE; ENCBS906GPZ

DR   GEO; GSM580027

DR   GEO; GSM580028

DR   GEO; GSM651571

DR   GEO; GSM945256

DR   GEO; GSM945288

DR   GEO; GSM1374525

DR   ICLC; HTL03003

DR   IZSLER; BS CL 129

DR   JCRB; JCRB9068

DR   KCB; KCB 200408YJ

DR   KCB; KCB 200971YJ

DR   KCLB; 21573

DR   Lonza; 46

DR   NCBI_Iran; C497

DR   NIH-ARP; 103-306

DR   PRIDE; PXD000589

DR   PRIDE; PXD000623

DR   PRIDE; PXD000680

DR   PRIDE; PXD000933

DR   PRIDE; PXD001468

DR   PRIDE; PXD001511

DR   PRIDE; PXD001711

DR   PRIDE; PXD002389

DR   PRIDE; PXD002395

DR   PRIDE; PXD002601

DR   PRIDE; PXD002676

DR   PRIDE; PXD003700

DR   PRIDE; PXD003896

DR   RCB; RCB1637

DR   TKG; TKG 0306

DR   TOKU-E; 31

DR   Wikidata; Q489618

RX   PubMed=886304;

RX   PubMed=21269460;

RX   PubMed=21502043;

RX   PubMed=22278370;

RX   PubMed=23325432;

RX   PubMed=24618588;

RX   PubMed=25182477;

RX   PubMed=25894527;

RX   PubMed=25903999;

RX   PubMed=27577262;

RX   PubMed=28196595;

WW   https://en.wikipedia.org/wiki/HEK_293_cells

WW   http://hek293.com/

WW   http://hek293genome.org/v2/

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=HEK293

WW   http://www.proteinatlas.org/learn/cellines

WW   http://141.61.102.20/mxdb/project/show/9191407937500

WW   http://www.addexbio.com/productdetail?pid=76

WW   http://fluoview.magnet.fsu.edu/gallery/cells/hek/hekcells.html

WW   http://en.vircell.com/products/293-cell-line/

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/2/cell-lines-detail-176.html

WW   http://web.archive.org/web/20140910211526/http://webserver.mbi.ufl.edu/~shaw/293.html

WW   http://tcpaportal.org/mclp/

CC   Part of: ENCODE project common cell types; tier 3.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: ~24-30 hours (DSMZ).

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

CC   Omics: Cell surface proteome.

CC   Omics: Deep antibody staining analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Genome sequenced.

CC   Omics: DNA methylation analysis.

CC   Omics: H3K4me3 ChIP-seq epigenome analysis.

CC   Omics: Methylated arginine analysis by proteomics.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: Transcriptome analysis.

CC   Omics: Virome analysis using proteomics.

CC   Misspelling: Occasionally 'HECK293'.

ST   Source(s): ATCC; CLS; DSMZ; ECACC; JCRB; KCLB; PubMed=11416159; RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 12,14 (ATCC; CLS; DSMZ; ECACC; KCLB; PubMed=11416159; RCB)

ST   D13S317: 12 (JCRB; TKG)

ST   D16S539: 9,13 (ATCC; ECACC; JCRB; RCB; TKG)

ST   D16S539: 9 (CLS; DSMZ)

ST   D18S51: 18 (CLS)

ST   D18S51: 17,18 (PubMed=11416159)

ST   D21S11: 28,30.2

ST   D3S1358: 15,17

ST   D5S818: 8,9

ST   D7S820: 11,12

ST   D8S1179: 12,14

ST   FGA: 23

ST   Penta D: 9,10

ST   Penta E: 7,15

ST   TH01: 7,9.3

ST   TPOX: 11

ST   vWA: 16,19

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   HEK293 (+Galpha16) AequoScreen

AC   CVCL_5I96

WW   http://www.perkinelmer.com/Catalog/Product/ID/ES-000-A26

CC   Transfected with: UniProtKB; P07164; Aequorin.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK293 482R

AC   CVCL_0296

SY   482R-HEK293; HEK-293 482R; HEK 293 482R

DR   MCCL; MCC:0000186

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK293 AequoScreen

AC   CVCL_5I97

WW   http://www.perkinelmer.com/Catalog/Product/ID/ES-000-A30

CC   Transfected with: UniProtKB; P07164; Aequorin.

CC   Transfected with: HGNC; 4383; GNA15.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK293 Cav3.1

AC   CVCL_HC62

SY   HEK-293 Cav3.1c; Q-31

RX   PubMed=10648811;

RX   PubMed=17477828;

WW   https://www.kerafast.com/product/2886/low-voltage-activated-lva-t-type-ca-channel-cav3-hek293-cell-lines

CC   Transfected with: HGNC; 1394; CACNA1G.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK293 Cav3.2

AC   CVCL_HC63

SY   Hh8-5

RX   PubMed=12080115;

RX   PubMed=17477828;

WW   https://www.kerafast.com/product/2886/low-voltage-activated-lva-t-type-ca-channel-cav3-hek293-cell-lines

CC   Transfected with: HGNC; 1395; CACNA1H.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK293 Cav3.3

AC   CVCL_HC64

SY   LT9-8

RX   PubMed=12080115;

RX   PubMed=17477828;

WW   https://www.kerafast.com/product/2886/low-voltage-activated-lva-t-type-ca-channel-cav3-hek293-cell-lines

CC   Transfected with: HGNC; 1396; CACNA1I.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   HEK293 eGFP-AEBP2

AC   CVCL_HC69

DR   ENCODE; ENCBS638MCL

DR   ENCODE; ENCBS715MMR

CC   Transfected with: HGNC; 24051; AEBP2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_U427 ! Flp-In-T-REx-293

SX   Female

CA   Transformed cell line

//

ID   HEK293 eGFP-ATF2

AC   CVCL_HC70

DR   ENCODE; ENCBS268PXW

DR   ENCODE; ENCBS818PXJ

CC   Transfected with: HGNC; 784; ATF2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_U427 ! Flp-In-T-REx-293

SX   Female

CA   Transformed cell line

//

ID   HEK293 eGFP-BCL11B

AC   CVCL_HC71

DR   ENCODE; ENCBS395FBP

DR   ENCODE; ENCBS923OML

CC   Transfected with: HGNC; 13222; BCL11B.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_U427 ! Flp-In-T-REx-293

SX   Female

CA   Transformed cell line

//

ID   HEK293 eGFP-CTCF

AC   CVCL_HC72

DR   ENCODE; ENCBS268XWC

DR   ENCODE; ENCBS454VNJ

CC   Transfected with: HGNC; 13723; CTCF.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_U427 ! Flp-In-T-REx-293

SX   Female

CA   Transformed cell line

//

ID   HEK293 eGFP-EGR2

AC   CVCL_HC73

DR   ENCODE; ENCBS738RNR

DR   ENCODE; ENCBS970WCY

CC   Transfected with: HGNC; 3239; EGR2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_U427 ! Flp-In-T-REx-293

SX   Female

CA   Transformed cell line

//

ID   HEK293 eGFP-GFI1B

AC   CVCL_HC74

DR   ENCODE; ENCBS320GSB

DR   ENCODE; ENCBS321IHW

CC   Transfected with: HGNC; 4238; GFI1B.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_U427 ! Flp-In-T-REx-293

SX   Female

CA   Transformed cell line

//

ID   HEK293 eGFP-GLI4

AC   CVCL_HC75

DR   ENCODE; ENCBS601JDX

DR   ENCODE; ENCBS966YJO

CC   Transfected with: HGNC; 4320; GLI4.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_U427 ! Flp-In-T-REx-293

SX   Female

CA   Transformed cell line

//

ID   HEK293 eGFP-GLIS1

AC   CVCL_HC76

DR   ENCODE; ENCBS300BBW

DR   ENCODE; ENCBS695XFP

CC   Transfected with: HGNC; 29525; GLIS1.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_U427 ! Flp-In-T-REx-293

SX   Female

CA   Transformed cell line

//

ID   HEK293 eGFP-GLIS2

AC   CVCL_HC77

DR   ENCODE; ENCBS101WTD

DR   ENCODE; ENCBS627NYN

CC   Transfected with: HGNC; 29450; GLIS2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_U427 ! Flp-In-T-REx-293

SX   Female

CA   Transformed cell line

//

ID   HEK293 eGFP-INSM2

AC   CVCL_HC78

DR   ENCODE; ENCBS121NOF

DR   ENCODE; ENCBS748WVG

CC   Transfected with: HGNC; 17539; INSM2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_U427 ! Flp-In-T-REx-293

SX   Female

CA   Transformed cell line

//

ID   HEK293 eGFP-KLF1

AC   CVCL_HC79

DR   ENCODE; ENCBS211CSP

DR   ENCODE; ENCBS870ICB

CC   Transfected with: HGNC; 6345; KLF1.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_U427 ! Flp-In-T-REx-293

SX   Female

CA   Transformed cell line

//

ID   HEK293 eGFP-KLF17

AC   CVCL_HC80

DR   ENCODE; ENCBS328EZX

DR   ENCODE; ENCBS485LHG

CC   Transfected with: HGNC; 18830; KLF17.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_U427 ! Flp-In-T-REx-293

SX   Female

CA   Transformed cell line

//

ID   HEK293 eGFP-KLF7

AC   CVCL_HC81

DR   ENCODE; ENCBS079LXY

DR   ENCODE; ENCBS184IBZ

CC   Transfected with: HGNC; 6350; KLF7.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_U427 ! Flp-In-T-REx-293

SX   Female

CA   Transformed cell line

//

ID   HEK293 eGFP-KLF8

AC   CVCL_HC82

DR   ENCODE; ENCBS132UZL

DR   ENCODE; ENCBS960DYO

CC   Transfected with: HGNC; 6351; KLF8.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_U427 ! Flp-In-T-REx-293

SX   Female

CA   Transformed cell line

//

ID   HEK293 eGFP-KLF9

AC   CVCL_HC83

DR   ENCODE; ENCBS321GAS

DR   ENCODE; ENCBS659BWP

CC   Transfected with: HGNC; 1123; KLF9.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_U427 ! Flp-In-T-REx-293

SX   Female

CA   Transformed cell line

//

ID   HEK293 eGFP-MAZ

AC   CVCL_HC84

DR   ENCODE; ENCBS099PTU

DR   ENCODE; ENCBS373QTO

DR   ENCODE; ENCBS541TCN

CC   Transfected with: HGNC; 6914; MAZ.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_U427 ! Flp-In-T-REx-293

SX   Female

CA   Transformed cell line

//

ID   HEK293 eGFP-MYNN

AC   CVCL_HC85

DR   ENCODE; ENCBS187WDU

DR   ENCODE; ENCBS898VIL

CC   Transfected with: HGNC; 14955; MYNN.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_U427 ! Flp-In-T-REx-293

SX   Female

CA   Transformed cell line

//

ID   HEK293 eGFP-OSR2

AC   CVCL_HC86

DR   ENCODE; ENCBS582ZUH

DR   ENCODE; ENCBS927YCP

CC   Transfected with: HGNC; 15830; OSR2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_U427 ! Flp-In-T-REx-293

SX   Female

CA   Transformed cell line

//

ID   HEK293 eGFP-OVOL3

AC   CVCL_HC87

DR   ENCODE; ENCBS294AQJ

DR   ENCODE; ENCBS465UQI

CC   Transfected with: HGNC; 14186; OVOL3.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_U427 ! Flp-In-T-REx-293

SX   Female

CA   Transformed cell line

//

ID   HEK293 eGFP-PRDM1

AC   CVCL_HC88

DR   ENCODE; ENCBS153AXP

DR   ENCODE; ENCBS830CXI

CC   Transfected with: HGNC; 9346; PRDM1.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_U427 ! Flp-In-T-REx-293

SX   Female

CA   Transformed cell line

//

ID   HEK293 eGFP-PRDM10

AC   CVCL_HC89

DR   ENCODE; ENCBS002NWR

DR   ENCODE; ENCBS154XJI

CC   Transfected with: HGNC; 13995; PRDM10.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_U427 ! Flp-In-T-REx-293

SX   Female

CA   Transformed cell line

//

ID   HEK293 eGFP-PRDM12

AC   CVCL_HC90

DR   ENCODE; ENCBS395UVF

DR   ENCODE; ENCBS568ALT

CC   Transfected with: HGNC; 13997; PRDM12.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_U427 ! Flp-In-T-REx-293

SX   Female

CA   Transformed cell line

//

ID   HEK293 eGFP-REST

AC   CVCL_HC91

DR   ENCODE; ENCBS064MAI

DR   ENCODE; ENCBS988LBI

CC   Transfected with: HGNC; 9966; REST.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_U427 ! Flp-In-T-REx-293

SX   Female

CA   Transformed cell line

//

ID   HEK293 eGFP-SALL4

AC   CVCL_HC92

DR   ENCODE; ENCBS247KOX

CC   Transfected with: HGNC; 15924; SALL4.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_U427 ! Flp-In-T-REx-293

SX   Female

CA   Transformed cell line

//

ID   HEK293 eGFP-SP2

AC   CVCL_HC93

DR   ENCODE; ENCBS525GEV

DR   ENCODE; ENCBS974ABS

CC   Transfected with: HGNC; 11207; SP2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_U427 ! Flp-In-T-REx-293

SX   Female

CA   Transformed cell line

//

ID   HEK293 eGFP-SP3

AC   CVCL_HC94

DR   ENCODE; ENCBS227SEC

DR   ENCODE; ENCBS451MRF

CC   Transfected with: HGNC; 11208; SP3.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_U427 ! Flp-In-T-REx-293

SX   Female

CA   Transformed cell line

//

ID   HEK293 eGFP-SP7

AC   CVCL_HC95

DR   ENCODE; ENCBS387JTD

DR   ENCODE; ENCBS516AIH

DR   ENCODE; ENCBS983QBQ

CC   Transfected with: HGNC; 17321; SP7.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_U427 ! Flp-In-T-REx-293

SX   Female

CA   Transformed cell line


您正在向 biovector.net  发送关于产品 细胞株Cell Lines 32-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心 的询问

点击“立即发送”后,我们将在1个工作日内与您取得联系。